News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Provepharm receives FDA marketing approval in US for BLUDIGO, its indigo carmine injection drug product
Wednesday, July 13, 2022Provepharm a French company specialized in the development of pharmaceutical applications today announces that it has received FDA New Drug Approval for the marketing of BLUDIGO its indigo carmine injectable Indigotindisulfonate Sodium drug product B...
Saphetor Partners With PTC Therapeutics to Advance Awareness of Clinical Programs in Rare Diseases
Wednesday, July 13, 2022Saphetor a global precision medicine company and the creator of VarSome The Human Genomics Community and variant interpretation platform announced today a partnership with PTC Therapeutics International Limited The open genomics community VarSomecom...
Bruker Announces Three New GHz NMR Systems Orders for Functional Structural Biology and Clinical Phenomics Research
Tuesday, July 12, 2022At the Euromar Conference Bruker announced three new customer orders for GHz systems which will incorporate novel compact GHz NMR magnets for structural biology applications and clinical research in singlestory laboratories The new Ascend Evo GHz...
Perrigo's HRA Pharma Submits Application to FDA for First-Ever OTC Birth Control Pill
Tuesday, July 12, 2022Perrigo Company plc a leading global provider of Consumer SelfCare Products today announced that HRA Pharma a Perrigo company has submitted its application to the United States Food and Drug Administration FDA for the firstever overthecounter OTC bir...
Sobi to license loncastuximab tesirine from ADC Therapeutics
Friday, July 08, 2022Sobi today announced an exclusive license agreement with ADC Therapeutics SA to develop and commercialise loncastuximab tesirine for use in haematology and other indications of large unmet medical need in Europe and most international markets Loncast...
Northwest Biotherapeutics Announces Filing of Application for License for Commercial Manufacturing at Sawston, UK Facility
Thursday, July 07, 2022Northwest Biotherapeutics a biotechnology company developing DCVax personalized immune therapies for solid tumor cancers today announced that an application for license of the manufacturing facility in Sawston UK for commercial manufacturing of cellu...
WuXi STA Opens New Large-scale Oligonucleotide and Peptide Manufacturing Facility
Thursday, July 07, 2022WuXi STA a subsidiary of WuXi AppTec today announced the opening of a new largescale oligonucleotide and peptide manufacturing facility at its Changzhou campus The new facility underscores WuXi STAs ongoing commitment to enhance its capacity and capa...
Iveric Bio and DelSiTech Enter Exclusive Agreement for Development of Sustained Release Zimura®
Wednesday, July 06, 2022IVERIC bio Inc and DelSiTech Ltd announced today an exclusive global license agreement providing Iveric Bio with the right to develop and commercialize new formulations of Zimura avacincaptad pegol using DelSiTechs silicabased sustained release techn...
Kyowa Kirin Expands License Agreement with Synaffix and Takes Exclusive Target Rights Based on Latest Positive ADC Data
Friday, July 01, 2022Synaffix BV a biotechnology company focused on commercializing its clinicalstage platform technology for the development of antibodydrug conjugates ADCs with bestinclass therapeutic index today announces that Kyowa Kirin Co Ltd Kyowa Kirin TSE a glob...
BeiGene Announces Late-Breaking Data at ESMO GI Showing Overall Survival Benefit for Tislelizumab Plus Chemotherapy in First-Line Advanced or Metastatic Esophageal
Thursday, June 30, 2022BeiGene a global sciencedriven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide today announced new data from RATIONALE a global Phase trial evaluating t...
